Why Doximity (DOCS) Dipped More Than Broader Market Today Zacks Equity Research Fri, October 16, 2026 at 5:15 PM EDT 3 min read DOCS -1.68% ^GSPC -1.09% ^DJI -0.34% Trade DOCS on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
In the latest trading session, Doximity (DOCS) closed at $30.71, marking a -2.51% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 1.09% for the day. Meanwhile, the Dow experienced a drop of 0.34%, and the technology-dominated Nasdaq saw a decrease of 2.15%.
Heading into today, shares of the medical social networking site had gained 18.56% over the past month, outpacing the Medical sector's gain of 2.68% and the S&P 500's gain of 2.44%.
The investment community will be closely monitoring the performance of Doximity in its forthcoming earnings report. The company is scheduled to release its earnings on November 5, 2026. The company's earnings per share (EPS) are projected to be $0.34, reflecting a 24.44% decrease from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $170.66 million, reflecting a 1.27% rise from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.33 per share and a revenue of $675.74 million, demonstrating changes of -12.5% and +4.79%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Doximity. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. As of now, Doximity holds a Zacks Rank of #3 (Hold).
In terms of valuation, Doximity is currently trading at a Forward P/E ratio of 23.61. This denotes a discount relative to the industry average Forward P/E of 33.2.
We can additionally observe that DOCS currently boasts a PEG ratio of 13.73. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical Info Systems was holding an average PEG ratio of 3.14 at yesterday's closing price.
The Medical Info Systems industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 83, finds itself in the top 34% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Doximity, Inc. (DOCS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
